Form 10-Q Sorrento Therapeutics, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Sorrento Therapeutics (SRNE) Reports Q3 Loss of $0.03/Share
November 16, 2015 6:38 AM ESTSorrento Therapeutics (NASDAQ: SRNE) reported Q3 EPS of ($0.03), versus ($0.27) reported last year. Revenue for the quarter came in at $1.1 million, versus $1.28 million reported last year.
For earnings history and earnings-related data on Sorrento Therapeutics (SRNE) click here.
... More